太仓市沿江临沪，地处沿海经济带和长三角经济圈核心位置，距离上海张江药谷和苏州BioBAY均只需1小时车程，高铁900秒抵达上海虹桥站，2027年地铁接轨上海。太仓港是长江外贸第一大港，位列全球集装箱港口第22位。太仓将生物医药作为重点发展的战略性新兴产业，围绕新药研发生产、医疗器械、医药服务外包等领域，已集聚了昭衍新药、康乃德生物、中美冠科、珀金埃尔默、含光微纳、思纳福等500余家生物医药企业，形成了完善的上下游产业链，年营业收入超300亿元。
Taicang is not only borders Shanghai but also faces the Yangtze River, located in the core position of the coastal economic belt and the Yangtze River Delta economic circle. It is only about an one-hour drive both from Shanghai Zhangjiang Pharmaceutical Valley and Suzhou BioBAY and 900 seconds from Taicang railway station to Shanghai Hongqiao railway station. In additon, the subway will be connected to Shanghai in 2027. Taicang port is the largest foreign trade port on the Yangtze River and the 22th in the global container ports. Taicang prioritized Biomedical as a strategic industry, with a focus on new medical development and production, medical devices, and pharmaceutical outsourcing services. The biomedical industry has gathered nearly 500 biomedical enterprises in the city, including Joinn Laboratories, Connect Biopharmaceuticals, Crown Bioscience, PerkinElmer, HiComp Microtech, Sinafu Medical Technology and other potential biomedical enterprises, already formed a complete industrial chain, annual operating revenue exceeding 30 billion yuan.